V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16688458 | 330035966 | ED617 | 4160 | X723 | 1 | 2016-03-24 | NELARABINE | 330015415 | 330008716 | 330010440 |
| 16688459 | 330035969 | ECL01 | 50 | X724 | 1 | 2014-01-19 | CYTARABINE | 330019584 | 330008902 | 330010626 |
| 16688462 | 330035971 | EE813 | 18 | null | 1 | null | PEMBROLIZUMAB | 330021284 | 330005550 | 330010743 |
| 16688464 | 330035974 | EE813 | 60 | X721 | 1 | 2018-09-11 | CYCLOPHOSPHAMIDE | 330022807 | 330005675 | 330010814 |
| 16688465 | 330035974 | EUJ01 | 1 | null | 1 | 2018-09-11 | PACLITAXEL | 330022807 | 330005675 | 330010814 |
| 16688466 | 330035974 | EEI00 | 82.5 | X721 | 2 | 2018-09-11 | CISPLATIN | 330022807 | 330005675 | 330010814 |
| 16688467 | 330035974 | EE813 | 4080 | X722 | 2 | 2018-09-12 | DACARBAZINE | 330022807 | 330005675 | 330010814 |
| 16688468 | 330035975 | EE813 | 53 | X731 | 1 | null | MITOXANTRONE | 330023338 | 330005734 | 330010848 |
| 16688469 | 330035975 | EK1PP | 36 | null | 2 | null | ETOPOSIDE | 330023338 | 330005734 | 330010848 |
| 16688470 | 330035975 | EE813 | 1000 | X724 | 2 | null | IBRUTINIB | 330023338 | 330005734 | 330010848 |
| 16688471 | 330035975 | ELW | 160 | X721 | 1 | null | CARBOPLATIN | 330023338 | 330005734 | 330010848 |
| 16688472 | 330035975 | EK1PP | 750 | X731 | 1 | null | BEVACIZUMAB | 330023338 | 330005734 | 330010848 |
| 16688473 | 330035975 | EK1PP | 10 | X721 | 1 | null | CISPLATIN | 330023338 | 330005734 | 330010848 |
| 16688474 | 330035975 | EK1PP | 4080 | X729 | 3 | null | CYTARABINE | 330023338 | 330005734 | 330010848 |
| 16688475 | 330035976 | ENR01 | 50 | X722 | 2 | 2017-02-24 | CYTARABINE | 330023532 | 330005763 | 330010863 |
| 16688476 | 330035976 | ED301 | 12.5 | X724 | 2 | 2017-02-24 | BCG | 330023532 | 330005763 | 330010863 |
| 16688477 | 330035976 | EEI00 | 10 | null | 2 | 2017-02-25 | ETOPOSIDE | 330023532 | 330005763 | 330010863 |
| 16688478 | 330035978 | ETG01 | 660 | X724 | 2 | 2015-07-03 | CYTARABINE | 330024869 | 330005951 | 330010971 |
| 16688479 | 330035978 | ETG | 1150 | X722 | 2 | 2015-07-04 | OFATUMUMAB | 330024869 | 330005951 | 330010971 |
| 16688480 | 330035978 | E1UZ0 | 55 | X724 | 2 | 2015-07-23 | NOT CHEMO | 330024869 | 330005951 | 330010971 |
| 16688481 | 330035978 | EWR01 | 170 | X722 | 5 | 2015-07-23 | BORTEZOMIB | 330024869 | 330005951 | 330010971 |
| 16688482 | 330035979 | Haqrsvarq | 460 | X721 | 1 | 2014-12-09 | IFOSFAMIDE | 330025006 | 330005968 | 330010983 |
| 16688483 | 330035980 | EPH | 2 | X724 | 1 | null | METHOTREXATE | 330002306 | 330005998 | 330010999 |
| 16688484 | 330035981 | Haqrsvarq | null | null | 1 | 2017-01-28 | CYCLOPHOSPHAMIDE | 330021494 | 330006133 | 330011083 |
| 16688485 | 330035981 | EK1PP | 50 | X724 | 2 | 2017-01-28 | IFOSFAMIDE | 330021494 | 330006133 | 330011083 |
| 16688486 | 330035983 | Haqrsvarq | null | null | 2 | null | METHOTREXATE | 330002909 | 330003370 | 330011196 |
| 16688487 | 330035983 | EWR01 | 40 | X724 | 2 | null | IFOSFAMIDE | 330002909 | 330003370 | 330011196 |
| 16688488 | 330035983 | EWR01 | 10 | X722 | 2 | null | FLUDARABINE | 330002909 | 330003370 | 330011196 |
| 16688489 | 330035984 | ETG | 3 | X724 | null | 2017-05-22 | NOT CHEMO | 330005891 | 330003704 | 330011301 |
| 16688490 | 330035985 | EKCPC | 0 | X723 | 1 | 2018-10-15 | STEROID | 330008126 | 330003981 | 330011407 |
| 16688491 | 330035986 | EE101 | 0 | X723 | 2 | 2016-12-28 | FLUDARABINE | 330008372 | 330004046 | 330011426 |
| 16688492 | 330035987 | EEI00 | 8 | null | 2 | 2016-03-31 | TEMOZOLOMIDE | 330008395 | 330004056 | 330011429 |
| 16688493 | 330035987 | EOI | 30 | X721 | 1 | 2016-04-07 | NOT CHEMO | 330008395 | 330004056 | 330011429 |
| 16688494 | 330035988 | EUJ01 | 1000 | null | 2 | 2017-08-15 | RITUXIMAB | 330021811 | 330005619 | 330011872 |
| 16688495 | 330035988 | EOI | 9.2 | X721 | 1 | 2017-08-15 | CETUXIMAB | 330021811 | 330005619 | 330011872 |
| 16688496 | 330035990 | EWR01 | 1 | null | 1 | 2016-10-26 | BORTEZOMIB | 330000450 | 330003033 | 330012071 |
| 16688497 | 330035990 | E1UZ0 | 48 | X724 | 1 | 2016-10-26 | VINCRISTINE | 330000450 | 330003033 | 330012071 |
| 16688498 | 330035991 | EGU02 | 8 | X723 | 2 | null | ETOPOSIDE | 330010739 | 330008328 | 330012275 |
| 16688499 | 330035991 | ERA20 | 4080 | null | 2 | null | CYCLOPHOSPHAMIDE | 330010739 | 330008328 | 330012275 |
| 16688503 | 330035996 | EK1PP | 1 | null | 1 | 2014-01-14 | BEVACIZUMAB | 330001888 | 330000375 | 330000740 |
| 16688512 | 330036001 | ENW | 585 | null | 2 | 2018-06-23 | PERTUZUMAB | 330008637 | 330011215 | 330002325 |
| 16688513 | 330036002 | EGU02 | 2.05 | X724 | 1 | 2016-05-31 | FLUDARABINE | 330008719 | 330001317 | 330002342 |
| 16688514 | 330036007 | EWR01 | 300 | X724 | 1 | null | CYTARABINE | 330011615 | 330001530 | 330002841 |
| 16688515 | 330036008 | EOI | 200 | X721 | 1 | 2014-11-26 | CETUXIMAB | 330014016 | 330001899 | 330003769 |
| 16688516 | 330036008 | ELW | 1.5 | null | 2 | 2014-11-26 | CARBOPLATIN | 330014016 | 330001899 | 330003769 |
| 16688517 | 330036008 | EQ3 | 4 | X721 | 2 | 2014-12-03 | NOT CHEMO | 330014016 | 330001899 | 330003769 |
| 16688518 | 330036009 | EOI | 900 | X724 | 2 | null | STEROID | 330014695 | 330001938 | 330003873 |
| 16688519 | 330036009 | EEI00 | 90 | X724 | 2 | null | MERCAPTOPURINE | 330014695 | 330001938 | 330003873 |
| 16688520 | 330036010 | ETG | 15 | null | 1 | 2015-05-11 | VINCRISTINE | 330014753 | 330012668 | 330003885 |
| 16688521 | 330036010 | EK1PP | 65 | null | 1 | 2015-05-11 | NOT CHEMO | 330014753 | 330012668 | 330003885 |